HK1064953A1 - Compositions for nasal administration of insulin - Google Patents

Compositions for nasal administration of insulin

Info

Publication number
HK1064953A1
HK1064953A1 HK04107874A HK04107874A HK1064953A1 HK 1064953 A1 HK1064953 A1 HK 1064953A1 HK 04107874 A HK04107874 A HK 04107874A HK 04107874 A HK04107874 A HK 04107874A HK 1064953 A1 HK1064953 A1 HK 1064953A1
Authority
HK
Hong Kong
Prior art keywords
insulin
compositions
nasal administration
nasal
administration
Prior art date
Application number
HK04107874A
Other languages
English (en)
Inventor
Toshikazu Oki
Takashi Hanafusa
Shunki Haruta
Original Assignee
Translational Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translational Res Ltd filed Critical Translational Res Ltd
Publication of HK1064953A1 publication Critical patent/HK1064953A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK04107874A 2001-07-05 2004-10-13 Compositions for nasal administration of insulin HK1064953A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001204784 2001-07-05
PCT/JP2002/006721 WO2003004048A1 (en) 2001-07-05 2002-07-03 Compositions for nasal administration of insulin

Publications (1)

Publication Number Publication Date
HK1064953A1 true HK1064953A1 (en) 2005-02-08

Family

ID=19041200

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04107874A HK1064953A1 (en) 2001-07-05 2004-10-13 Compositions for nasal administration of insulin

Country Status (11)

Country Link
US (2) US6906027B2 (xx)
EP (1) EP1413311A4 (xx)
JP (1) JP4721212B2 (xx)
KR (1) KR20030027108A (xx)
CN (1) CN100341567C (xx)
AU (1) AU2002346143B2 (xx)
CA (1) CA2433583A1 (xx)
HK (1) HK1064953A1 (xx)
MX (1) MXPA03005980A (xx)
RU (1) RU2299743C2 (xx)
WO (1) WO2003004048A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1413311A4 (en) * 2001-07-05 2005-10-19 Translational Res Ltd COMPOSITIONS FOR NASAL ADMINISTRATION OF INSULIN
WO2004073729A1 (ja) * 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
EP1607117A4 (en) 2003-03-27 2007-10-24 Bioactis Ltd APPLICATOR FOR POWDER MEDICATION IN THE NOSE CAVE
WO2006016530A1 (ja) * 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
US7115561B2 (en) * 2004-09-22 2006-10-03 Patterson James A Medicament composition and method of administration
WO2008078730A1 (ja) 2006-12-26 2008-07-03 Translational Research, Ltd. 経鼻投与用製剤
UA90013C2 (ru) 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
DK2964199T3 (da) 2013-03-04 2020-06-15 Besins Healthcare Lu Sarl Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler
DK3049059T3 (da) * 2013-09-24 2022-01-31 Satsuma Pharmaceuticals Inc Intranasal dhe formulering til behandlingen af hovedpine
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
WO2019130701A1 (ja) * 2017-12-26 2019-07-04 旭化成株式会社 セルロース粉末
CN113423400A (zh) 2018-12-11 2021-09-21 小蜜橘制药公司 用于治疗或预防头痛的组合物、装置和方法
CA3138846A1 (en) * 2019-05-16 2020-11-19 Shin Nippon Biomedical Laboratories, Ltd. Powder formulation for intranasal administration, and manufacturing method thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
JPS6242888A (ja) 1985-08-21 1987-02-24 カシオ計算機株式会社 太陽電池を備えたｉｃカ−ド
JP2505430B2 (ja) * 1986-11-04 1996-06-12 帝人株式会社 塩基性アミノ酸を含有する経鼻投与用粉末状組成物
JPH0715963B2 (ja) 1987-08-31 1995-02-22 松下電器産業株式会社 半導体装置
JP2802488B2 (ja) * 1995-02-08 1998-09-24 有限会社ドット 経鼻吸収用生理活性ペプチド組成物
WO1997031626A1 (fr) 1996-02-27 1997-09-04 Teijin Limited Composition pulverulente destinee a une adminstration nasale
JP3197221B2 (ja) 1996-02-27 2001-08-13 帝人株式会社 吸収性が改善された粉末状経鼻投与組成物
US6835389B1 (en) 1998-08-26 2004-12-28 Teijin Limited Powder Composition for nasal administration
JP4338313B2 (ja) 1998-08-26 2009-10-07 帝人株式会社 粉末状経鼻組成物
EP1413311A4 (en) * 2001-07-05 2005-10-19 Translational Res Ltd COMPOSITIONS FOR NASAL ADMINISTRATION OF INSULIN

Also Published As

Publication number Publication date
WO2003004048A1 (en) 2003-01-16
RU2004103187A (ru) 2005-06-10
MXPA03005980A (es) 2003-09-10
KR20030027108A (ko) 2003-04-03
JP4721212B2 (ja) 2011-07-13
CA2433583A1 (en) 2003-01-16
EP1413311A4 (en) 2005-10-19
US6906027B2 (en) 2005-06-14
US20050158250A1 (en) 2005-07-21
CN100341567C (zh) 2007-10-10
AU2002346143B2 (en) 2007-10-04
EP1413311A1 (en) 2004-04-28
JPWO2003004048A1 (ja) 2005-11-24
CN1491114A (zh) 2004-04-21
RU2299743C2 (ru) 2007-05-27
US20040063615A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
IL161214A0 (en) Compositions for delivery of drug combinations
EP1466610A4 (en) MEDICAL COMPOSITIONS FOR NASAL ABSORPTION
IL158862A0 (en) An insulin composition for pulmonary administration
EP1438086A4 (en) NOSE NEEDLE
GB0126151D0 (en) Administration of medicaments by vaporisation
PL356358A1 (en) Solid dosage form of someticone for oral administration
PL366874A1 (en) Nasal drug delivery devices
PL367180A1 (en) Stabilized oral pharmaceutical composition
EP1407785A4 (en) MEDICAL COMPOSITIONS
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
AU2002322719A1 (en) Delivery of therapeutic capable agents
HK1064953A1 (en) Compositions for nasal administration of insulin
AU2002346143A1 (en) Compositions for nasal administration of insulin
HK1065257A1 (en) Medicinal composition
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
HUP0400115A3 (en) Pharmaceutical composition for the intramuscular administration of fulvestrant
AU2002357935A1 (en) Dosage form for providing time-varying patterns of drug delivery
GB0228305D0 (en) Therapeutic composition for respiratory delivery
HUP0401862A3 (en) Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them
HUP0200253A2 (en) Pharmaceutical compositions for combination therapy
GB0114746D0 (en) Medicinal composition
EP1413314A4 (en) MEDICAL COMPOSITIONS
HUP0103049A3 (en) Use of fluexetine for preparation of pharmaceutical compositions
GB0127359D0 (en) Pharmaceutical compositions for inhalation
GB0124010D0 (en) Pharmaceutical compositions for inhalation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120703